ExoProTher Medical ltd

General Data

Reg Number
515596310
Sector
Biomed
Established
2017
No. of Employees
8
Stage
R&D
Additional Funding
0

Technology

AnserBio supplies healthy p53 protein to cancer cells using natural nano-particles, called exosomes that can be delivered by multiple administration routes for cancer treatment.

Targeted Customers

Cancer patients, Pharmaceuticals industry.

Management personnel

Lana Volokh - CEO & Co-Founder
Alex Tendler - CTO & Co-Founder

Contact information

Name
Website
http://www.exoprother.com
Country
Israel
Zip
3688847

Tags

BiotechnologyCancerLife SciencesMedical DevicesMedTechNanotechnologyOncologyPharmaceuticalsTherapeutics

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

Technological Incubators 2020
Technological Incubators 2020
2023
To the full list